Intravenous Thrombolysis in Patients With White Matter Hyperintensities in the WAKE-UP Trial
Benedikt M. Frey(Universität Hamburg), Florent Boutitie(Université Claude Bernard Lyon 1), Alina Königsberg(Universität Hamburg), Ewgenia Barow(Universität Hamburg), Götz Thomalla(Universität Hamburg), Robin Lemmens(VIB-KU Leuven Center for Microbiology), Salvador Pedraza(Hospital Clínic de Barcelona), Bastian Cheng(Universität Hamburg), F Shenas(Universität Hamburg), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Keith W. Muir(University of Glasgow), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Tae‐Hee Cho(Université Claude Bernard Lyon 1), Jens Fiehler(Universität Hamburg), Martin Ebinger(Universität Hamburg), Eckhard Schlemm(Defense Information Systems Agency), Ivana Galinović(Universität Hamburg), Christian Gerloff(Universität Hamburg), Jochen B. Fiebach(Pathodiagnostik Berlin), Matthias Endres(German Center for Neurodegenerative Diseases), Claus Z. Simonsen(Universität Hamburg)
Cited by 14
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
|New England Journal of Medicine|2018|856